Upload Avatar (500 x 500)
Xiao Gengfu
Life Science
University of Chinese Academy of Sciences
Hubei
Language: Chinese, English
Virus
Biochemistry
Molecular Biology
Pathogenesis
Infection
Antiviral
Vaccine
Immunology
Genetics
Proteomics
Areas of Focus
- Biochemistry of Viruses
- Virology
Work Experience
- 1995-09~Present - Wuhan University - PhD in Science
- 1989-09~Present - Tongji Medical University - Master's in Medicine
- 1984-09~Present - Tongji Medical University - Bachelor's in Medicine
- 2020-12-25~Present - Hubei Jiangxia Laboratory - Director
- 2018-05-08~Present - National Key R&D Program 'Protein Machine' - Member
Academic Background & Achievements
- 1995-09 PhD in Science: Wuhan University
- 1989-09 Master's in Medicine: Tongji Medical University
- 1984-09 Bachelor's in Medicine: Tongji Medical University
Publications
- A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in mice, 9th Author, 2024
- Synthesis of maleimide-braced peptide macrocycles and their potential anti-SARS-CoV-2 mechanisms, 11th Author, 2023
- Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB, 5th Author, 2023
- Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, 10th Author, 2023
- High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors, 11th Author, 2023
- Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner, 11th Author, 2023
- CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, 24th Author, 2022
- Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library, 11th Author, 2022
- Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2, 9th Author, 2022
- Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19, 10th Author, 2022
Awards
- State Council Special Government Allowance (2018): First Prize, National Level
